UPTRAVI® Resources and Support

PAH Therapy Support and Resources: From Prescriptions to Maintenance

Supporting Every Step of Your Patient’s Journey With UPTRAVI®

Janssen is committed to providing you and your patients with a robust selection of educational resources and support programs that will help you navigate their PAH journey.

Step 1: INITIATIONStart Patients on UPTRAVI®

Insurance doesn’t have to be burdensome. Janssen knows the process to help navigate patient coverage.

Janssen CarePath is your one source for access, affordability, and treatment support for your patients. Janssen CarePath helps verify insurance coverage for your patients, helps find financial assistance options for eligible patients, and provides ongoing support to help patients start and stay on prescribed Janssen medications.

When you enroll your patients in Janssen CarePath:

Our Therapy Access Managers (TAMs) field team can help educate you on navigating the PA process to get patients started on therapy.

For more information, call a Janssen CarePath Care Coordinator at 866-228-3546, Monday-Friday, 8 am to 8 pm ET.

Multilingual phone support available.

Print and fill out the UPTRAVI® Patient Enrollment Form to get your patients started with UPTRAVI®. The Patient Enrollment Form is not optimized for mobile devices. Please print, sign, and fax to Janssen CarePath.

Note: An alternate form is available for Veterans Affairs (VA) patients: UPTRAVI® VA PATIENT ENROLLMENT FORM.

Download the Guide to the UPTRAVI® Patient Enrollment Form, which provides detailed instructions to help you fill out the form.

Janssen CarePath Oral PAH Savings Program can help eligible patients save on their out-of-pocket medication costs for UPTRAVI®. Depending on their health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. Your eligible patients will pay $5 per prescription fill, with a $20,000 maximum program benefit per calendar year across all oral PAH therapies in the program. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. See full eligibility requirements at

Step 2: TITRATION―Choose Nurse Support for Your Patients

After you, as the treating healthcare professional (HCP), have made the decision to prescribe UPTRAVI®, you may choose for your patient to receive nurse education support as they start therapy.

For patients to receive this service, you must check “yes” on the enrollment form to opt in to the nurse support and titration education program.

Within 48 hours of your patient’s receipt of their first UPTRAVI® shipment, an SP Nurse can have an interaction with your patient.

During these visits with your patient, the nurse can:

Educate the patient on what to expect as they start therapy with UPTRAVI®

Ensure the patient’s understanding of reaching their personal dose

Help to address potential patient misconceptions about UPTRAVI® dosing

Provide the patient and/or their caregiver with recommendations on when to call their HCP

The information provided is educational in nature and not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, provide case management services, or serve as a reason to prescribe.

Step 3: SUPPORT―Help Patients Manage PAH

Once a decision has been made to prescribe a Janssen PAH medication, PAH Companion withMe is a suite of patient support resources customized for your patients’ specific questions, needs, and interests. One-on-one educational conversations with a dedicated PAH Companion—coupled with access to current PAH tools and resources—help your patients take a more active role in their care.

A dedicated PAH Companion is ready to answer your patients’ questions and help them navigate their treatment experience. Patients who have enrolled can connect with their personal PAH Companion by calling 866-300-1818, Monday–Friday, 8 AM–9 PM ET.

PAH Companion withMe is limited to education for patients about their PAH therapy, its administration, and/or their disease, and is not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, or provide case management services.


UPTRAVI® Dose Adjustment Phase Guide for Patients

This guide helps you set goals and expectations with patients who are starting treatment with UPTRAVI®. It can be used as a conversation tool and is available to patients to help them stay on treatment by tracking and sharing how they’re feeling with their healthcare team.

UPTRAVI® Adverse Reactions Management Tool and Titration Guide

This guide offers dosing, titration, and pill identification information to help get your patients started with UPTRAVI®, as well as adverse reaction management guidance for PAH therapies targeting the prostacyclin pathway.